Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Innovative Solutions Opening (ISO)

TA1 CVD Agent – Reliable Agentic Care Management Development and deployment of a patient-facing, multimodal agentic system that performs clinical functions autonomously and semi-autonomously with the clinical team, integrated in real-time with the patient’s EHR(s) and wearables. TA1 aims to develop a clinical tool that provides care management to patients with chronic CVD, such as heart failure and post-myocardial infarction (“heart attack”). This CVD agent will be ‘prescribed’ to patients by their clinician (primary care physician or cardiologist) and will interact directly with them to provide continuous outpatient management. It will leverage patient’s inputs and data to perform advanced clinical reasoning. This clinical AI agent will function in coordination with and as an extension of the clinical team, with the ability to adapt its functions to the clinical context and the patient’s preferences. See attached file. This solicitation has some or all Federal funding, additional requirements may apply.